Isogen Secures $7 Million Credit Facility

NEWARK, DE, Jun 01 (MARKET WIRE) --
Isogen LLC announced today that it has closed on a credit facility with
Wilmington Trust totaling $7 million. The facility is made up of three
term loans which will be used for purchasing machinery and equipment,
working capital, and recasting existing debt.

"I'm pleased that our credit facility with Wilmington Trust has closed.
This financing will enable us to expedite our growth strategy. Through the
expansion of our Science Center we will double our capacity, and increase
our revenue at an accelerated rate," shared Les Edwards, Isogen's CEO.

About Isogen

Through its Science Center in Newark, Delaware, Isogen provides advanced
sterile manufacturing for potent and non-potent therapeutics for the
critical clinical/commercial scale manufacturing transition. The Company
delivers a fully integrated suite of services including formulation, tech
transfer, laboratory, and validation services for the contract filling of
liquids and lyophilized formulations for vaccines, mAbs, and other
synthetic and biologically derived therapeutics. For further information,
contact Robin Uhl, ruhl@isogenllc.com, 201-394-1927.

Information contained in this press release, other than historical
information, may be considered forward-looking in nature as such it is
based upon certain assumptions and is subject to various risks and
uncertainties, which may not be controllable by the Company. To the extent
that these assumptions prove to be incorrect, or should any of these risks
or uncertainties materialize, the actual results may vary materially from
those that were anticipated.

CONTACT:
Robin Uhl
Isogen
201.394.1927
Email Contact

Copyright 2009, Market Wire, All rights reserved.

-0-